SCHEMBL8945706

SCHEMBL8945706

CCN(CC)C(=O)Oc1ccc(Cl)cc1

nearest known ligand 0.81

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.81
KMT2A Q03164 1/20 0.81
SMN1; SMN2 Q16637 3/20 0.61
HSD17B10 Q99714 1/20 0.61
LMNA P02545 4/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
SRD5A1 P18405 1/20 0.54
MAOA P21397 2/20 0.51
TSHR P16473 1/20 0.50
RAB9A P51151 1/20 0.48
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.46
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9302685 0.90 MEN1 (1.00) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL5623889 0.85 MEN1 (0.88) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL8945322 0.83 KMT2A (0.85) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL10013782 0.81 MEN1 (0.81) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL12928357 0.81 MEN1 (0.81) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL2531879 0.81 MEN1 (0.81) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL19439086 0.81 MEN1 (0.81) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL5623546 0.81 MEN1 (0.81) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL23214505 0.81 MEN1 (0.68) MEN1KMT2ASMN1; SMN2HSD17B10LMNA
SCHEMBL29663966 0.81 MEN1 (0.68) MEN1KMT2ASMN1; SMN2HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5510375-A VIRICIDES TREATING INFECTION CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS AND AIDS WARNER-LAMBERT COMPANY (US) 1996-04-23 US disclosed